Dr. Mario Javier Pineda, MD, PhD

Dr. Pineda practices at Ironwood Cancer & Research Centers in Chandler, Arizona.

Dr. Pineda's NPI, 1942497359, was assigned on September 29, 2007. Dr. Pineda graduated from University of Washington School of Medicine in 2007. Dr. Pineda holds Arizona license 54173.

Dr. Pineda's primary practice is Ironwood Cancer & Research Centers, at 685 S Dobson Rd, Chandler, AZ 85224 in Maricopa County. The practice phone is (480) 821-2838.

Dr. Pineda's primary practice is Ironwood Cancer & Research Centers in Chandler, Arizona. Dr. Pineda is also affiliated with Dignity Health Chandler Regional Medical Center. The medical group on file is Ironwood Cancer & Research Centers. Dmand AI also links Dr. Pineda to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pineda practices, 4 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Pineda's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Pineda is licensed in Arizona.

CMS data shows 512 Medicare services from Dr. Pineda across 7 procedure codes in 2024, for 171 Medicare patients. Medicare paid $45,695 for them. Every service was in an office.

CMS counts 171 Medicare patients who saw Dr. Pineda in 2024. The largest group is 65 to 74, with 87 patients. 74% of them have high cholesterol, and 73% have high blood pressure. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pineda's median patient age at 62, with 98% women.

In 2024, Dr. Pineda wrote 415 Medicare Part D claims for 131 patients. 82% of them were for generic drugs. CMS names the drug for 275 of them, across 12 drugs with 11 or more claims each, at $364,839 in total drug cost. In 2023, CMS named 300 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Pineda for performance year 2024. Dr. Pineda accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pineda as offering telehealth. CMS counts 11 procedures of removal of the uterus by Dr. Pineda, more than 85% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Pineda, published from 2015 to 2022. The most frequent topics are Ovarian Neoplasms, Adenocarcinoma and Endometrial Neoplasms. Dr. Pineda's most frequent co-authors are Daniela E. Matei, MD, Ronald D. Alvarez, MD and Emma L. Barber.

Dmand AI links Dr. Pineda to 4 clinical trials, 3 of them phase 2 studies. Conditions studied include Fallopian Tube Diseases, Carcinoma, Ovarian Epithelial and Ovarian Neoplasms. Northwestern University sponsors the most, 2. Open Payments lists research payments to Dr. Pineda that name 1 trial.

CMS Open Payments shows 257 general payments to Dr. Pineda from 53 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $613. It also lists 25 research payments totaling $3,750 from 2016 to 2019, naming 1 clinical trial.

Dr. Pineda graduated from University of Washington School of Medicine in 2007.